Apraz Pharmaceuticals Private Limited
About Apraz Pharmaceuticals Private Limited
Data last updated:
Apraz Pharmaceuticals Private Limited is a private limited company based in Patna, Bihar, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 04 April 2013 and has been in existence for over 13 years.
The company is registered with the Registrar of Companies (ROC), Patna, under CIN U74999BR2013PTC019997. Its GSTIN is 10AALCA8225H1ZX (Bihar).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Ranjeet Kumar Gupta (Managing Director) and Smita Gupta.
Its last annual general meeting (AGM) was held on 30 September 2019, and its latest financial statements are for the year ended 31 March 2019. The registered office is at C/O Rahul Kumar Dariyapur Gola Kadam Kuan, Patna, Bihar, India – 800004.
As per the financials filed for FY 2019, the company reported a revenue of ₹6.57 Lakh, a growth of 54% compared to the previous year. For the same year it recorded a net loss of ₹27,775 (net margin -4.2%) and EBITDA of ₹34,249 (EBITDA margin 5.2%). Revenue has grown at a compounded annual rate (CAGR) of 34% over five years.
As per MCA filings, the company has open charges of ₹6 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Apraz Pharmaceuticals Private Limited's registered office is in Patna, Bihar. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressC/O Rahul Kumar Dariyapur Gola Kadam Kuan, Patna, Bihar, India – 800004
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Apraz Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Apraz Pharmaceuticals is hospital and medical care. In detail, this covers medical and dental practice, nursing, pathology, blood bank services, etc..
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q2 | Medical and dental practice, Nursing, pathology, blood bank services, etc. |
To see the full business activity and turnover split of Apraz Pharmaceuticals Private Limited, buy the company report.
Financials of Apraz Pharmaceuticals Private Limited
FY 2019 filings availableApraz Pharmaceuticals Private Limited reported revenue of ₹6.57 Lakh (up 54% YoY) for FY 2019.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 34% over five years, including 54% growth in the latest year. EBITDA rose 111% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | ₹6.57 Lakh | ||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹34,249 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹27,775 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.2% | ||||
| Net Profit Margin | -4.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Apraz Pharmaceuticals Private Limited, buy the company report.
Board of directors of Apraz Pharmaceuticals Private Limited
Apraz Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Smita Gupta | Director | 04 Apr 2013 | 13 Years 6 Months | Current |
| Ranjeet Kumar Gupta | Managing Director | 04 Apr 2013 | 13 Years 6 Months | Current |
Auditor
Apraz Pharmaceuticals Private Limited is audited by RAMA KANT JHA & CO for the financial year 2019.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| RAMA KANT JHA & CO | FY 2019 | 007201C |
Shareholding
The shareholding of Apraz Pharmaceuticals Private Limited is on record for 3 financial years, the latest being FY 2019, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2019 | FY 2016 | FY 2015 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Apraz Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 07 Oct 2016 | 100063619 | Others | ₹6 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Apraz Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Apraz Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Apraz Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 10AALCA8225H1ZX | Bihar | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Apraz Pharmaceuticals Private Limited, buy the company report.
Recent activity
Apraz Pharmaceuticals Private Limited has 2 board changes on record since 2013: 2 appointments. The latest: Ranjeet Kumar Gupta was appointed as Managing Director on 04 Apr 2013.
Frequently asked questions
Apraz Pharmaceuticals is an active private limited company based in Patna, Bihar, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 04 April 2013 (13+ years old) and is registered under CIN U74999BR2013PTC019997.
Apraz Pharmaceuticals has 2 current directors:
- Ranjeet Kumar Gupta - Managing Director
- Smita Gupta - Director
The latest financial statements of Apraz Pharmaceuticals on record with the MCA are for the year ended 31 March 2019. Its last annual general meeting was held on 30 September 2019. Year-wise statements from 2015 are in the company report.
The GSTIN of Apraz Pharmaceuticals is 10AALCA8225H1ZX, registered in Bihar.
The CIN (Corporate Identification Number) of Apraz Pharmaceuticals is U74999BR2013PTC019997. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Apraz Pharmaceuticals was incorporated on 04 April 2013, making it 13+ years old. It is registered with the Registrar of Companies, Patna.
Ranjeet Kumar Gupta was appointed as Managing Director on 04 Apr 2013. Smita Gupta was appointed as Director on 04 Apr 2013.
The registered office of Apraz Pharmaceuticals is at CO Rahul Kumar Dariyapur Gola Kadam Kuan, Patna, Bihar, India – 800004.
Apraz Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Apraz Pharmaceuticals has open charges of ₹6 Lakh and no satisfied charges on record as per latest MCA filings.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
